AbCellera Biologics, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA00288U1066
USD
4.24
-0.4 (-8.62%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1285993,
    "name": "AbCellera Biologics, Inc.",
    "stock_name": "AbCellera Biologics, Inc.",
    "full_name": "AbCellera Biologics, Inc.",
    "name_url": "stocks-analysis/abcellera-biologics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "4.24",
    "chg": -0.4,
    "chgp": "-8.62%",
    "dir": -1,
    "prev_price": "4.64",
    "mcapval": "1,281.15",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "CA00288U1066",
    "curr_date": "Jan 23",
    "curr_time": "",
    "bse_nse_vol": "1.94 M",
    "exc_status": "Active",
    "traded_date": "Jan 23, 2026",
    "traded_date_str": "2026 01 23",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/abcellera-biologics-inc-1285993-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "AbCellera Biologics Hits Day Low of $3.42 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abcellera-biologics-hits-day-low-of-342-amid-price-pressure-3686568",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AbCelleraBiolog_priceRelatedfactors_3686568.png",
        "date": "2025-11-10 17:53:36",
        "description": "AbCellera Biologics, Inc. faced notable stock volatility on November 7, 2025, with a significant decline amid contrasting market performance. The company has struggled with negative results over the past ten quarters, low liquidity indicators, and a market capitalization of USD 1,246 million, classifying it as a small-cap entity."
      },
      {
        "title": "AbCellera Biologics Hits Day Low of $4.67 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abcellera-biologics-hits-day-low-of-467-amid-price-pressure-3676154",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AbCelleraBiolog_priceRelatedfactors_3676154.png",
        "date": "2025-11-06 16:20:08",
        "description": "AbCellera Biologics, Inc. faced a notable decline in stock value, contrasting with the broader market's performance. Despite recent setbacks and negative results over ten quarters, the company has shown strong year-over-year growth. Institutional investors maintain significant holdings, indicating ongoing confidence in its fundamentals amid current challenges."
      }
    ],
    "total": 16,
    "sid": "1285993",
    "stock_news_url": "https://www.marketsmojo.com/news/abcellera-biologics-inc-1285993"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}
stock-recommendationAnnouncement
Icon
No announcement available
stock-recommendationCorporate Actions
Corporate Actions
info
Icon
No corporate action available